Cynthia Collins - Net Worth and Insider Trading

Cynthia Collins Net Worth

The estimated net worth of Cynthia Collins is at least $134,343 dollars as of 2024-11-13. Cynthia Collins is the CEO of Editas Medicine Inc and owns about 43,760 shares of Editas Medicine Inc (EDIT) stock worth over $134,343. Details can be seen in Cynthia Collins's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cynthia Collins has not made any transactions after 2021-02-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Cynthia Collins

Cynthia Collins Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cynthia Collins owns 6 companies in total, including Editas Medicine Inc (EDIT) , DermTech Inc (CNACU) , and Genvec Inc (GNVC) among others .

Click here to see the complete history of Cynthia Collins’s form 4 insider trades.

Insider Ownership Summary of Cynthia Collins

Ticker	Comapny	Transaction Date	Type of Owner
EDIT	Editas Medicine Inc	2021-02-09	director
CNACU	DermTech Inc	2020-06-17	director
GNVC	Genvec Inc	2013-01-23	director & President & CEO
		2019-08-29	director
		2023-06-15	director
		2021-08-01	director

Cynthia Collins Latest Holdings Summary

Cynthia Collins currently owns a total of 1 stock. Cynthia Collins owns 43,760 shares of Editas Medicine Inc (EDIT) as of February 9, 2021, with a value of $134,343.

Latest Holdings of Cynthia Collins

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
EDIT	Editas Medicine Inc	2021-02-09	43,760	3.07	134,343

Holding Weightings of Cynthia Collins

Cynthia Collins Form 4 Trading Tracker

According to the SEC Form 4 filings, Cynthia Collins has made a total of 2 transactions in Editas Medicine Inc (EDIT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Editas Medicine Inc is the sale of 1,262 shares on February 9, 2021, which brought Cynthia Collins around $84,112.

Insider Trading History of Cynthia Collins

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cynthia Collins Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Cynthia Collins Ownership Network

Ownership Network List of Cynthia Collins

No Data

Ownership Network Relation of Cynthia Collins

Cynthia Collins Owned Company Details

What does Editas Medicine Inc do?

Who are the key executives at Editas Medicine Inc?

Cynthia Collins is the director of Editas Medicine Inc. Other key executives at Editas Medicine Inc include SVP & CHIEF MEDICAL OFFICER Baisong Mei , director & CEO Gilmore Neil O'neill , and EVP & CHIEF SCIENTIFIC OFFICER Linda Burkly .

Editas Medicine Inc (EDIT) Insider Trades Summary

Over the past 18 months, Cynthia Collins made no insider transaction in Editas Medicine Inc (EDIT). Other recent insider transactions involving Editas Medicine Inc (EDIT) include a net sale of 1,988 shares made by Bruce Eaton , a net sale of 32,292 shares made by Baisong Mei , and a net sale of 98,056 shares made by Gilmore Neil O'neill .

In summary, during the past 3 months, insiders sold 2,073 shares of Editas Medicine Inc (EDIT) in total and bought 0 shares, with a net sale of 2,073 shares. During the past 18 months, 166,559 shares of Editas Medicine Inc (EDIT) were sold and 45,000 shares were bought by its insiders, resulting in a net sale of 121,559 shares.

Editas Medicine Inc (EDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Editas Medicine Inc Insider Transactions

No Available Data

What does DermTech Inc do?

Who are the key executives at DermTech Inc?

Cynthia Collins is the director of DermTech Inc. Other key executives at DermTech Inc include Chief Commercial Officer Todd Michael Wood , director & Chief Executive Officer John Dobak , and Chief Operating Officer Claudia Ibarra .

DermTech Inc (CNACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of DermTech Inc (CNACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DermTech Inc (CNACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DermTech Inc (CNACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

DermTech Inc Insider Transactions

No Available Data

What does Genvec Inc do?

Who are the key executives at Genvec Inc?

Cynthia Collins is the director & President & CEO of Genvec Inc. Other key executives at Genvec Inc include director & President and CEO Douglas J Swirsky , 10 percent owner Mmcap International Inc. Spc , and other: See Explanation of Responses Ecor1 Capital Fund Qualified, L.p. .

Genvec Inc (GNVC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Genvec Inc (GNVC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genvec Inc (GNVC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genvec Inc (GNVC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Genvec Inc Insider Transactions

No Available Data

What does DermTech Inc do?

Who are the key executives at DermTech Inc?

Cynthia Collins is the director of DermTech Inc. Other key executives at DermTech Inc include Chief Financial Officer Kevin M Sun , Chief Operating Officer Claudia Ibarra , and General Counsel Ramin Akhavan .

DermTech Inc (DMTKQ) Insider Trades Summary

Over the past 18 months, Cynthia Collins made no insider transaction in DermTech Inc (DMTKQ). Other recent insider transactions involving DermTech Inc (DMTKQ) include a net sale of 23,295 shares made by Kevin M Sun , a net sale of 21,158 shares made by Claudia Ibarra , and a net sale of 12,075 shares made by Ramin Akhavan .

In summary, during the past 3 months, insiders sold 0 shares of DermTech Inc (DMTKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 61,870 shares of DermTech Inc (DMTKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 61,870 shares.

DermTech Inc (DMTKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

DermTech Inc Insider Transactions

No Available Data

What does Poseida Therapeutics Inc do?

Who are the key executives at Poseida Therapeutics Inc?

Cynthia Collins is the director of Poseida Therapeutics Inc. Other key executives at Poseida Therapeutics Inc include President & Cell Therapy Kristin Yarema , 10 percent owner Malin Life Sciences Holdings Ltd , and director & 10 percent owner & Chief Executive Officer Eric Ostertag .

Poseida Therapeutics Inc (PSTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Poseida Therapeutics Inc (PSTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Poseida Therapeutics Inc (PSTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Poseida Therapeutics Inc (PSTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Poseida Therapeutics Inc Insider Transactions

No Available Data

What does Certara Inc do?

Who are the key executives at Certara Inc?

Cynthia Collins is the director of Certara Inc. Other key executives at Certara Inc include PRESIDENT & INTEGRATED DRUG DEV Patrick F Smith , President & Software Leif E Pedersen , and See Remarks Richard M. Traynor .

Certara Inc (CERT) Insider Trades Summary

Over the past 18 months, Cynthia Collins made no insider transaction in Certara Inc (CERT). Other recent insider transactions involving Certara Inc (CERT) include a net sale of 43,940 shares made by Patrick F Smith , a net sale of 15,000 shares made by Richard M. Traynor , and a net sale of 102,448 shares made by Leif E Pedersen .

In summary, during the past 3 months, insiders sold 56,633 shares of Certara Inc (CERT) in total and bought 0 shares, with a net sale of 56,633 shares. During the past 18 months, 161,388 shares of Certara Inc (CERT) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 156,388 shares.

Certara Inc (CERT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Certara Inc Insider Transactions

No Available Data

Cynthia Collins Mailing Address

Above is the net worth, insider trading, and ownership report for Cynthia Collins. You might contact Cynthia Collins via mailing address: 65 West Watkins Mill Road, Gaithersburg Md 20878.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.